Who is it for?
Viveve is suitable for women with vaginal laxity and/or stress urinary incontinence.
What is the treatment for?
Viveve is targeted at treating vaginal laxity (especially post childbirth), which can cause a decrease in sexual satisfaction and physical sensations during intercourse, and at treating mild to moderate stress urinary incontinence.
How does the treatment work?
Viveve™ is a clinically-proven, single-session radiofrequency (RF) treatment that safely and comfortably renews and strengthens vaginal tissue and responsiveness by stimulating the body’s natural collagen formation process, reducing or eliminating laxity and stress urinary incontinence. The pulsed delivery of RF causes collagen contraction in the underlying tissues, leading to the stimulation of new collagen formation over the following 30 to 90 days and continued improvement at 6 and 12 months.
Benefits of the treatment
During a Viveve™ treatment, the overlying tissue is not damaged so there is little to no downtime or pain and no local anaesthesia is required during the procedure.
Duration of treatment
A typical Viveve treatment takes 30-45 minutes.
How many sessions are required?
Typically only one treatment is required although the treatment may be repeated after three months if required. Results are seen after a few weeks with maximum results by 3 months.
There is no downtime and patients are able to resume their normal activities immediately afterwards.